Delphi Management Inc. MA cut its stake in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) by 24.9% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,513 shares of the semiconductor company’s stock after selling 4,149 shares during the period. Lam Research comprises approximately 1.6% of Delphi Management Inc. MA’s investment portfolio, making the stock its 5th biggest position. Delphi Management Inc. MA’s holdings in Lam Research were worth $1,675,000 as of its most recent filing with the SEC.
Other large investors also recently modified their holdings of the company. IMG Wealth Management Inc. bought a new stake in Lam Research during the 2nd quarter worth $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research during the second quarter valued at about $27,000. Strategic Wealth Investment Group LLC bought a new stake in shares of Lam Research during the second quarter worth about $29,000. Delos Wealth Advisors LLC bought a new stake in shares of Lam Research during the second quarter worth about $30,000. Finally, REAP Financial Group LLC acquired a new position in shares of Lam Research in the second quarter valued at approximately $31,000. 84.61% of the stock is currently owned by institutional investors.
Key Headlines Impacting Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Lam hit a new 52-week high as market optimism around AI-led demand and improving margin outlooks pushed shares higher. Lam Research (NASDAQ:LRCX) Hits New 52-Week High – Here’s Why
- Positive Sentiment: Reports point to AI-driven equipment demand boosting margins and the company narrative; this is a key fundamental driver investors are pricing in. Lam Research (LRCX) Is Up 7.4% After AI-Driven Equipment Demand Lifts Margins And Outlook Narrative
- Positive Sentiment: Coverage from Yahoo and other outlets highlights how Lam is benefitting from AI tailwinds — reinforcing the growth story and supporting higher forward multiples. Here’s How Lam Research Corporation (LRCX) is Benefitting from AI
- Positive Sentiment: UBS reiterated a buy recommendation, which adds institutional validation to the rally and likely supported flows into the stock. UBS maintains Lam Research (LRCX) buy recommendation
- Positive Sentiment: An analyst upgrade pushed the stock higher in intraday trading, reflecting improving sell-side sentiment and likely short-term buying pressure. Lam Research (NASDAQ:LRCX) Trading 1.6% Higher After Analyst Upgrade
- Positive Sentiment: Multiple bullish write-ups (Zacks, MSN) frame LRCX as a long-term growth stock based on secular semiconductor equipment demand, supporting a longer-term bid. Why Lam Research (LRCX) is a top growth stock for the long term Why Lam Research (LRCX) is a Top Growth Stock for the Long-Term
- Neutral Sentiment: Unusually high options trading was reported, signaling elevated speculative interest or hedging activity; this can amplify intraday moves but is not a clear directional fundamental signal. Lam Research Target of Unusually High Options Trading (NASDAQ:LRCX)
- Neutral Sentiment: A short-interest data entry showed an anomalous/zero reading and flagged an increase that appears to be a data glitch; current reported short-interest metrics are unreliable and don’t meaningfully explain the move. (Internal short-interest entry)
Analyst Upgrades and Downgrades
Get Our Latest Stock Analysis on LRCX
Lam Research Stock Performance
LRCX stock opened at $177.24 on Thursday. The firm has a market cap of $222.62 billion, a PE ratio of 39.04, a price-to-earnings-growth ratio of 2.02 and a beta of 1.77. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The stock has a 50-day moving average price of $156.96 and a 200-day moving average price of $124.97. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $177.56.
Lam Research (NASDAQ:LRCX – Get Free Report) last released its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.22 by $0.04. The business had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The firm’s revenue was up 27.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, equities research analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current year.
Lam Research Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be paid a $0.26 dividend. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a dividend yield of 0.6%. Lam Research’s payout ratio is currently 22.91%.
Insider Activity at Lam Research
In related news, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction on Friday, November 14th. The shares were sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the transaction, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at $148,677,892.20. This represents a 3.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Vahid Vahedi sold 52,190 shares of the firm’s stock in a transaction on Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the sale, the senior vice president owned 251,047 shares of the company’s stock, valued at $34,870,428.30. The trade was a 17.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 102,608 shares of company stock worth $14,916,496 over the last quarter. 0.31% of the stock is currently owned by insiders.
Lam Research Company Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Further Reading
- Five stocks we like better than Lam Research
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Forget AI, This Will Be the Next Big Tech Breakthrough
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
